The newly approved extravascular closure device was designed for procedures with access sites from 6 to 12 French. It uses the same proprietary GRIP technology found in other Cordis interventional devices.

Among general cardiologists, compensation increased nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps.

Value-based payments can impact cardiology practices in many ways, helping cardiologists acquire new technology and boost patient care.

The new-look PFA system from Pulse Biosciences was designed to treat AFib with a single application that lasts less than two seconds.

Electrophysiology specialist Vivek Reddy, MD, and colleagues reviewed data from more than 17,000 patients, presenting their findings in Nature Medicine.

The new list of discounted drugs includes an anticoagulant, a beta-blocker used to treat atrial fibrillation and much more. 

The new algorithm from Tempus AI evaluates 12-lead ECG results, alerting users when a patient could be at risk of experiencing AFib within the next 12 months.

Persistent and paroxysmal atrial fibrillation appear to affect short- and long-term TAVR mortality rates in different ways, according to a new study of nearly 3,000 patients. Some trends fade over time, while others remain in place after many years.